News Image

Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations

Provided By GlobeNewswire

Last update: Oct 28, 2025

Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications

Read more at globenewswire.com

PALISADE BIO INC

NASDAQ:PALI (10/30/2025, 8:00:02 PM)

After market: 1.99 +0.05 (+2.58%)

1.94

-0.18 (-8.49%)



Find more stocks in the Stock Screener

Follow ChartMill for more